Digirad releases second quarter, first half results

TriMed Staff | | Health Imaging | Screening
Digirad Corporation has announced financial results for the second quarter and first half of 2005. For the three months ended June 30, 2005, consolidated revenue declined 11 percent to $15.5 million from $17.3 million for the same period of 2004.

The net loss for the second quarter of 2005 was $3.0 million. This compares to net income for the second quarter of 2004 of $103,000.

For the six months ended June 30, 2005, total revenue was $33.4 million. This compares to total revenue of $33.2 million for first half 2004.

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.